Bristol-Myers Squibb Company Ce (CELG-RI)
USD 0.04
(-11.76%)
USD 0.04
(-11.76%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 95.15 Billion USD | -1.72% |
| 2022 | 96.82 Billion USD | -11.43% |
| 2021 | 109.31 Billion USD | -7.74% |
| 2020 | 118.48 Billion USD | -8.82% |
| 2019 | 129.94 Billion USD | 1119.1% |
| 2018 | 10.65 Billion USD | -68.23% |
| 2017 | 33.55 Billion USD | -0.46% |
| 2016 | 33.7 Billion USD | 6.17% |
| 2015 | 31.74 Billion USD | -5.93% |
| 2014 | 33.74 Billion USD | -12.55% |
| 2013 | 38.59 Billion USD | 7.51% |
| 2012 | 35.89 Billion USD | 8.88% |
| 2011 | 32.97 Billion USD | 6.09% |
| 2010 | 31.07 Billion USD | 0.22% |
| 2009 | 31 Billion USD | 4.93% |
| 2008 | 29.55 Billion USD | 12.91% |
| 2007 | 26.17 Billion USD | 2.33% |
| 2006 | 25.57 Billion USD | -9.11% |
| 2005 | 28.13 Billion USD | -7.55% |
| 2004 | 30.43 Billion USD | 10.79% |
| 2003 | 27.47 Billion USD | 10.44% |
| 2002 | 24.87 Billion USD | -8.07% |
| 2001 | 27.05 Billion USD | 53.93% |
| 2000 | 17.57 Billion USD | 2.71% |
| 1999 | 17.11 Billion USD | 5.17% |
| 1998 | 16.27 Billion USD | 8.65% |
| 1997 | 14.97 Billion USD | 1.99% |
| 1996 | 14.68 Billion USD | 5.43% |
| 1995 | 13.92 Billion USD | 7.89% |
| 1994 | 12.91 Billion USD | 6.69% |
| 1993 | 12.1 Billion USD | 12.0% |
| 1992 | 10.8 Billion USD | 14.74% |
| 1991 | 9.41 Billion USD | 2.18% |
| 1990 | 9.21 Billion USD | 8.45% |
| 1989 | 8.49 Billion USD | 2.71% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 94.64 Billion USD | -4.43% |
| 2024 Q1 | 99.03 Billion USD | 4.07% |
| 2024 Q3 | 93.67 Billion USD | -1.03% |
| 2023 Q3 | 91.26 Billion USD | -2.38% |
| 2023 Q2 | 93.48 Billion USD | -0.84% |
| 2023 Q1 | 94.28 Billion USD | -2.62% |
| 2023 FY | 95.15 Billion USD | -1.72% |
| 2023 Q4 | 95.15 Billion USD | 4.27% |
| 2022 FY | 96.82 Billion USD | -11.43% |
| 2022 Q1 | 103.03 Billion USD | -5.74% |
| 2022 Q2 | 100.35 Billion USD | -2.6% |
| 2022 Q3 | 98.19 Billion USD | -2.15% |
| 2022 Q4 | 96.82 Billion USD | -1.4% |
| 2021 Q1 | 112.43 Billion USD | -5.1% |
| 2021 FY | 109.31 Billion USD | -7.74% |
| 2021 Q4 | 109.31 Billion USD | -1.42% |
| 2021 Q3 | 110.89 Billion USD | 0.09% |
| 2021 Q2 | 110.79 Billion USD | -1.46% |
| 2020 Q3 | 125.53 Billion USD | -1.98% |
| 2020 Q4 | 118.48 Billion USD | -5.62% |
| 2020 FY | 118.48 Billion USD | -8.82% |
| 2020 Q1 | 129.28 Billion USD | -0.51% |
| 2020 Q2 | 128.07 Billion USD | -0.94% |
| 2019 FY | 129.94 Billion USD | 1119.1% |
| 2019 Q4 | 129.94 Billion USD | 126.25% |
| 2019 Q1 | 25.31 Billion USD | 137.49% |
| 2019 Q2 | 46.5 Billion USD | 83.7% |
| 2019 Q3 | 57.43 Billion USD | 23.51% |
| 2018 Q3 | 33.73 Billion USD | 3.35% |
| 2018 FY | 10.65 Billion USD | -68.23% |
| 2018 Q4 | 10.65 Billion USD | -68.4% |
| 2018 Q2 | 32.64 Billion USD | -1.34% |
| 2018 Q1 | 33.08 Billion USD | -1.39% |
| 2017 Q3 | 33.97 Billion USD | 1.7% |
| 2017 Q2 | 33.4 Billion USD | 1.43% |
| 2017 Q1 | 32.93 Billion USD | -2.28% |
| 2017 FY | 33.55 Billion USD | -0.46% |
| 2017 Q4 | 33.55 Billion USD | -1.25% |
| 2016 Q4 | 33.7 Billion USD | -0.06% |
| 2016 FY | 33.7 Billion USD | 6.17% |
| 2016 Q1 | 31.89 Billion USD | 0.45% |
| 2016 Q2 | 32.83 Billion USD | 2.94% |
| 2016 Q3 | 33.72 Billion USD | 2.73% |
| 2015 Q4 | 31.74 Billion USD | -0.1% |
| 2015 Q1 | 33.57 Billion USD | -0.5% |
| 2015 Q3 | 31.77 Billion USD | -0.55% |
| 2015 Q2 | 31.95 Billion USD | -4.84% |
| 2015 FY | 31.74 Billion USD | -5.93% |
| 2014 FY | 33.74 Billion USD | -12.55% |
| 2014 Q2 | 33.5 Billion USD | 0.24% |
| 2014 Q1 | 33.42 Billion USD | -13.39% |
| 2014 Q3 | 33.45 Billion USD | -0.16% |
| 2014 Q4 | 33.74 Billion USD | 0.89% |
| 2013 Q2 | 36.25 Billion USD | 0.82% |
| 2013 Q4 | 38.59 Billion USD | 4.86% |
| 2013 Q3 | 36.8 Billion USD | 1.52% |
| 2013 Q1 | 35.95 Billion USD | 0.17% |
| 2013 FY | 38.59 Billion USD | 7.51% |
| 2012 Q2 | 31.66 Billion USD | -2.29% |
| 2012 Q3 | 36.04 Billion USD | 13.82% |
| 2012 Q4 | 35.89 Billion USD | -0.41% |
| 2012 FY | 35.89 Billion USD | 8.88% |
| 2012 Q1 | 32.4 Billion USD | -1.7% |
| 2011 Q2 | 31.83 Billion USD | 3.18% |
| 2011 Q4 | 32.97 Billion USD | 2.99% |
| 2011 Q3 | 32.01 Billion USD | 0.57% |
| 2011 FY | 32.97 Billion USD | 6.09% |
| 2011 Q1 | 30.85 Billion USD | -0.72% |
| 2010 Q1 | 30.75 Billion USD | -0.82% |
| 2010 FY | 31.07 Billion USD | 0.22% |
| 2010 Q4 | 31.07 Billion USD | -2.54% |
| 2010 Q3 | 31.88 Billion USD | 2.69% |
| 2010 Q2 | 31.05 Billion USD | 0.97% |
| 2009 Q4 | 31 Billion USD | 0.18% |
| 2009 Q1 | 29.69 Billion USD | 0.48% |
| 2009 FY | 31 Billion USD | 4.93% |
| 2009 Q3 | 30.95 Billion USD | 3.83% |
| 2009 Q2 | 29.8 Billion USD | 0.39% |
| 2008 Q2 | 28.06 Billion USD | 6.61% |
| 2008 Q3 | 28.47 Billion USD | 1.47% |
| 2008 FY | 29.55 Billion USD | 12.91% |
| 2008 Q4 | 29.55 Billion USD | 3.78% |
| 2008 Q1 | 26.32 Billion USD | 0.58% |
| 2007 FY | 26.17 Billion USD | 2.33% |
| 2007 Q3 | 26.09 Billion USD | -3.96% |
| 2007 Q1 | 26.09 Billion USD | 2.02% |
| 2007 Q4 | 26.17 Billion USD | 0.28% |
| 2007 Q2 | 27.17 Billion USD | 4.15% |
| 2006 Q2 | 27.4 Billion USD | -0.21% |
| 2006 FY | 25.57 Billion USD | -9.11% |
| 2006 Q1 | 27.46 Billion USD | -2.41% |
| 2006 Q3 | 27.21 Billion USD | -0.68% |
| 2006 Q4 | 25.57 Billion USD | -6.03% |
| 2005 Q1 | 28.4 Billion USD | -6.66% |
| 2005 FY | 28.13 Billion USD | -7.55% |
| 2005 Q4 | 28.13 Billion USD | 9.88% |
| 2005 Q3 | 25.6 Billion USD | 1.49% |
| 2005 Q2 | 25.23 Billion USD | -11.17% |
| 2004 Q4 | 30.43 Billion USD | 0.86% |
| 2004 Q1 | 28.36 Billion USD | 3.24% |
| 2004 Q2 | 28.98 Billion USD | 2.2% |
| 2004 Q3 | 30.17 Billion USD | 4.11% |
| 2004 FY | 30.43 Billion USD | 10.79% |
| 2003 Q2 | 25.91 Billion USD | 2.19% |
| 2003 Q3 | 26.52 Billion USD | 2.36% |
| 2003 Q1 | 25.36 Billion USD | 1.95% |
| 2003 Q4 | 27.47 Billion USD | 3.55% |
| 2003 FY | 27.47 Billion USD | 10.44% |
| 2002 FY | 24.87 Billion USD | -8.07% |
| 2002 Q3 | 24.96 Billion USD | 0.75% |
| 2002 Q4 | 24.87 Billion USD | -0.38% |
| 2002 Q1 | 24.91 Billion USD | -7.91% |
| 2002 Q2 | 24.78 Billion USD | -0.54% |
| 2001 Q4 | 27.05 Billion USD | 9.83% |
| 2001 Q2 | 17.47 Billion USD | -1.06% |
| 2001 FY | 27.05 Billion USD | 53.93% |
| 2001 Q3 | 24.63 Billion USD | 40.96% |
| 2001 Q1 | 17.66 Billion USD | 0.49% |
| 2000 FY | 17.57 Billion USD | 2.71% |
| 2000 Q4 | 17.57 Billion USD | 0.64% |
| 2000 Q3 | 17.46 Billion USD | 3.78% |
| 2000 Q2 | 16.83 Billion USD | -1.2% |
| 2000 Q1 | 17.03 Billion USD | -0.46% |
| 1999 Q1 | 15.98 Billion USD | -1.76% |
| 1999 Q2 | 16.21 Billion USD | 1.43% |
| 1999 Q3 | 16.61 Billion USD | 2.45% |
| 1999 Q4 | 17.11 Billion USD | 3.02% |
| 1999 FY | 17.11 Billion USD | 5.17% |
| 1998 Q1 | 15.24 Billion USD | 1.78% |
| 1998 Q3 | 14.92 Billion USD | 2.28% |
| 1998 Q4 | 16.27 Billion USD | 9.03% |
| 1998 FY | 16.27 Billion USD | 8.65% |
| 1998 Q2 | 14.59 Billion USD | -4.26% |
| 1997 Q2 | 14.52 Billion USD | -2.26% |
| 1997 Q4 | 14.97 Billion USD | 1.76% |
| 1997 FY | 14.97 Billion USD | 1.99% |
| 1997 Q1 | 14.86 Billion USD | 1.19% |
| 1997 Q3 | 14.71 Billion USD | 1.34% |
| 1996 Q3 | 14 Billion USD | 1.85% |
| 1996 FY | 14.68 Billion USD | 5.43% |
| 1996 Q1 | 13.82 Billion USD | -0.75% |
| 1996 Q2 | 13.75 Billion USD | -0.54% |
| 1996 Q4 | 14.68 Billion USD | 4.86% |
| 1995 FY | 13.92 Billion USD | 7.89% |
| 1995 Q1 | 13.45 Billion USD | 4.21% |
| 1995 Q2 | 13.57 Billion USD | 0.93% |
| 1995 Q3 | 13.38 Billion USD | -1.45% |
| 1995 Q4 | 13.92 Billion USD | 4.09% |
| 1994 Q3 | 12.85 Billion USD | 5.24% |
| 1994 Q4 | 12.91 Billion USD | 0.42% |
| 1994 Q1 | 12.28 Billion USD | 1.53% |
| 1994 Q2 | 12.21 Billion USD | -0.57% |
| 1994 FY | 12.91 Billion USD | 6.69% |
| 1993 Q2 | 10.89 Billion USD | 3.72% |
| 1993 FY | 12.1 Billion USD | 12.0% |
| 1993 Q3 | 10.96 Billion USD | 0.67% |
| 1993 Q4 | 12.1 Billion USD | 10.34% |
| 1993 Q1 | 10.5 Billion USD | -2.79% |
| 1992 Q4 | 10.8 Billion USD | 11.16% |
| 1992 FY | 10.8 Billion USD | 14.74% |
| 1992 Q1 | 9.26 Billion USD | -1.66% |
| 1992 Q2 | 9.34 Billion USD | 0.9% |
| 1992 Q3 | 9.71 Billion USD | 4.02% |
| 1991 FY | 9.41 Billion USD | 2.18% |
| 1991 Q3 | 9.26 Billion USD | 2.18% |
| 1991 Q4 | 9.41 Billion USD | 1.62% |
| 1991 Q1 | 9 Billion USD | -2.24% |
| 1991 Q2 | 9.06 Billion USD | 0.65% |
| 1990 Q1 | 8.62 Billion USD | 1.48% |
| 1990 Q2 | 8.96 Billion USD | 4.0% |
| 1990 Q3 | 9.12 Billion USD | 1.8% |
| 1990 Q4 | 9.21 Billion USD | 0.94% |
| 1990 FY | 9.21 Billion USD | 8.45% |
| 1989 FY | 8.49 Billion USD | 2.71% |
| 1989 Q4 | 8.49 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbbVie Inc. | 134.71 Billion USD | 29.361% |
| Bristol-Myers Squibb Company | 95.15 Billion USD | 0.0% |
| Johnson & Johnson | 167.55 Billion USD | 43.208% |
| Eli Lilly and Company | 64 Billion USD | -48.671% |
| Merck & Co., Inc. | 106.67 Billion USD | 10.795% |
| Novartis AG | 99.94 Billion USD | 4.789% |
| Organon & Co. | 12.05 Billion USD | -689.177% |
| Pfizer Inc. | 226.5 Billion USD | 57.987% |